Rise and shine—it’s Sunday at the Annual Meeting and a full day of robust and diverse programming awaits.
Today’s programming begins bright and early with 10 Meet-the-Expert sessions running concurrently from 7 – 7:45 a.m. CDT. Then, you don’t want to miss the Opening Ceremony, beginning at 7:45 a.m. CDT in Hall B-C at the convention center, where we’ll hear remarks from AACR CEO Margaret Foti, PhD, MD (hc), and from U.S. Food and Drug Administration Commissioner Robert M. Califf, MD.
The Opening Ceremony will also feature a live performance by the renowned Preservation Hall All-Stars Jazz Band, a special video presentation commemorating the 115th anniversary of the AACR, and several important award presentations.
Immediately following the Opening Ceremony, the Opening Plenary Session: Decoding Cancer Complexity, Integrating Science, Transforming Patient Outcomes will showcase the theme of the Annual Meeting by highlighting several examples of how researchers are decoding the complexities of cancer, from premalignancy all the way to the population level. The Opening Plenary Session begins at 9:45 a.m. CDT in Hall B-C of the convention center.
- More Here: Meeting officially launches Sunday morning with Opening Ceremony, followed by Opening Plenary Session
Today’s program includes nine award presentations and lectures, nine major symposia, and 11 minisymposia. And over the course of the meeting, there will be four in-depth Clinical Trials Plenary Sessions highlighting several novel therapies making their way to the clinic, some of which are being presented for the first time here at the meeting. Today’s schedule includes two of those sessions: Clinical Trials of Cellular Immunotherapies from 1 – 3:05 p.m. CDT in Hall B-C and Clinical Trials Targeting the DNA Damage Response and KRAS from 3 – 5:05 p.m. CDT in Great Hall AD.
Our focus on AACR Project GENIE continues today with a special session that will examine how different project teams are using Project GENIE data. Decoding Cancer Complexity and Transforming Patient Outcomes Using AACR Project GENIE will be held from 1 – 2 p.m. CDT in Room 343-345 at the convention center.
Also this afternoon, we will have the first two of this year’s three-part New Drugs on the Horizon special sessions, where we’ll hear about 12 innovative agents in the research pipeline that have recently entered, or are about to enter into phase I trials. New Drugs on the Horizon: Part 1 will be held from 1 – 2:30 p.m. CDT, followed by Part 2 at 3 p.m. CDT, both in La Nouvelle Orleans A-B. New Drugs on the Horizon: Part 3 will conclude the series tomorrow morning.
Be sure to make some time in your schedule to visit the 2022 Exhibits Show, which opens today at 1 p.m. CDT. The Exhibits Show is a great opportunity to see the latest products and services for laboratory and clinical research, and a great chance to interact and network with industry representatives and other attendees.
Before you leave the convention center for the night, you won’t want to miss this year’s Presidential Address by AACR President David A. Tuveson, MD, PhD, FAACR, who will discuss how basic research has led to clinical opportunities in pancreatic cancer. His address will begin at 5:30 p.m. CDT in La Nouvelle Orleans C.
Be sure to check AACR Meeting News each day for more meeting highlights, program previews, session recaps, and all the news from the Annual Meeting in New Orleans.